Vycor Medical Stock Annual Yield
VYCO Stock | USD 0.13 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Vycor Medical's long-term financial health and intrinsic value.
Vycor |
Vycor Medical OTC Stock Annual Yield Analysis
Vycor Medical's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Vycor Medical has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
Vycor Fundamentals
Return On Asset | -0.24 | |||
Profit Margin | (0.39) % | |||
Operating Margin | (0.31) % | |||
Current Valuation | 4.17 M | |||
Shares Outstanding | 32.53 M | |||
Shares Owned By Insiders | 64.50 % | |||
Price To Earning | (2.74) X | |||
Price To Sales | 2.60 X | |||
Revenue | 1.39 M | |||
Gross Profit | 1.26 M | |||
EBITDA | (252.02 K) | |||
Net Income | (435.66 K) | |||
Cash And Equivalents | 43.62 K | |||
Total Debt | 150 K | |||
Debt To Equity | 390.90 % | |||
Current Ratio | 0.15 X | |||
Book Value Per Share | (0.09) X | |||
Cash Flow From Operations | 21.37 K | |||
Earnings Per Share | (0.02) X | |||
Beta | 1.31 | |||
Market Capitalization | 3.03 M | |||
Total Asset | 935.36 K | |||
Retained Earnings | (24.68 M) | |||
Working Capital | (584 K) | |||
Current Asset | 559 K | |||
Current Liabilities | 1.14 M | |||
Z Score | -23.4 | |||
Net Asset | 935.36 K |
About Vycor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vycor Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vycor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vycor Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vycor Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vycor Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Vycor OTC Stock
0.42 | GE | GE Aerospace | PairCorr |
0.36 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
0.33 | INBX | Inhibrx Biosciences, | PairCorr |
0.33 | MSFT | Microsoft Aggressive Push | PairCorr |
0.32 | BA | Boeing | PairCorr |
The ability to find closely correlated positions to Vycor Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vycor Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vycor Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vycor Medical to buy it.
The correlation of Vycor Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vycor Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vycor Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vycor Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.